The Role of Angiogenesis in the Transformation of Plexiform Neurofibroma into Malignant Peripheral Nerve Sheath Tumors in Children With Neurofibromatosis Type 1

被引:21
作者
Gesundheit, Benjamin [2 ,4 ]
Parkin, Patricia [5 ]
Greenberg, Mark [4 ]
Baruchel, Sylvain [4 ]
Senger, Christof [6 ]
Kapelushnik, Josef [3 ]
Smith, Charles [6 ]
Klement, Giannoula Lakka [1 ]
机构
[1] Tufts Med Ctr, Floating Hosp Children, Dept Pediat Oncol, Boston, MA 02111 USA
[2] Int Ctr Cell Therapy & Canc Immunotherapy, Tel Aviv, Israel
[3] Dept Pediat Hematol & Oncol, Beer Sheva, Israel
[4] Hosp Sick Children, Div Hematol & Oncol, Toronto, ON M5G 1X8, Canada
[5] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada
[6] Hosp Sick Children, Dept Lab Med, Toronto, ON M5G 1X8, Canada
关键词
neurofibromatosis; angiogenesis; vascular endothelial growth factor (VEGF); vascular endothelial growth factor receptor-1 (VEGFR-1); vascular endothelial growth factor receptor-2 (VEGFR-2); alpha-smooth muscle actin (alpha-SMA); peripheral neurofibroma (PNF); malignant peripheral nerve sheet tumor (MPNST); FIBROBLAST-GROWTH-FACTOR; ANTIANGIOGENIC THERAPY; FACTOR MIDKINE; INHIBITION; EXPRESSION; NF1; EXPERIENCE; INDUCTION; ONCOGENES; GLIOMAS;
D O I
10.1097/MPH.0b013e3181e887c7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The role of angiogenesis in the transformation of peripheral neurofibroma (PNF) to malignant peripheral nerve sheath tumor (MPNST) in neurofibromatosis type 1 (NF1) remains elusive and forms the objective of this study. Experimental Design: Archival tissue from 5 children with NF1 and PNF, who developed MPNST between the ages of 8 and 15 years were analyzed for differences in microvasculature. The role of proangiogenic growth factors such as Vascular Endothelial Growth Factor (VEGF), and its receptors Flk-1 and Flt-1, and vessel maturity, defined as von Willebrand factor (vWf), alpha-smooth muscle actin(+) (SMA(+)), were evaluated by immuno-histochemistry. Results: A qualitative evaluation of the vasculature showed predominantly alpha-SMA+/vWf+ more stable vessels in PNF, and an irregular meshwork of alpha-SMA-/vWf+ endothelial cells structures in MPNST. In NF and PNF tumor cells were VEGF(-), in contrast to VEGF(+) tumor cells in MPNST. If present, the VEGF stain was confined mainly to the perivascular spaces in PNF, unlike the mainly stromal VEGF stain in MPNST. VEGF receptors also manifested a tumor stage-specific pattern. Flk-1 and Flt-1 were restricted to the mature, well-formed vasculature in PNF, but exhibited a diffuse pattern in MPNST. Conclusion: Our study provides a rare opportunity to document consistent and histologically detectable differences in the vascular organization of PNF and MPNST. It permits a pair-wise evaluation of the malignant conversion of benign PNF into its malignant counterpart, in the same patients. The phenotypic variations and characteristics of the vessels in these tumors are consistent with the idea that a strong proangiogenic drive contributes to the progressive growth in MPNST.
引用
收藏
页码:548 / 553
页数:6
相关论文
共 55 条
  • [1] Angelov L, 1999, CANCER RES, V59, P5536
  • [2] Neurogenic sarcomas: Experience at the University of Toronto
    Angelov, L
    Davis, A
    O'Sullivan, B
    Bell, R
    Guha, A
    [J]. NEUROSURGERY, 1998, 43 (01) : 56 - 64
  • [3] ASSAYS FOR ANGIOGENESIS - A REVIEW
    AUERBACH, R
    AUERBACH, W
    POLAKOWSKI, I
    [J]. PHARMACOLOGY & THERAPEUTICS, 1991, 51 (01) : 1 - 11
  • [4] NEUROFIBROMATOSIS AND CHILDHOOD LEUKEMIA
    BADER, JL
    MILLER, RW
    [J]. JOURNAL OF PEDIATRICS, 1978, 92 (06) : 925 - 929
  • [5] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    Benjamin, LE
    Golijanin, D
    Itin, A
    Pode, D
    Keshet, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165
  • [6] CT OF SARCOMATOUS DEGENERATION IN NEUROFIBROMATOSIS
    COLEMAN, BG
    ARGER, PH
    DALINKA, MK
    OBRINGER, AC
    RANEY, BR
    MEADOWS, AT
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1983, 140 (02) : 383 - 387
  • [7] How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: Nonverbal learning disabilities revisited
    Cutting, LE
    Koth, CW
    Denckla, MB
    [J]. DEVELOPMENTAL NEUROPSYCHOLOGY, 2000, 17 (01) : 29 - 47
  • [8] Dinney CPN, 1998, CANCER RES, V58, P808
  • [9] INTERFERON ALFA-2A THERAPY FOR LIFE-THREATENING HEMANGIOMAS OF INFANCY
    EZEKOWITZ, RAB
    MULLIKEN, JB
    FOLKMAN, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (22) : 1456 - 1463
  • [10] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182